Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?

S. Jauhar, S. Guloksuz, O. Andlauer, G. Lydall, J.G. Marques, L. Mendonca, I. Dumitrescu, C. Roventa, N. De Vriendt, J.S. van Zanten, F. Riese, I. Nwachukwu, A. Nawka, R. Psaras, N. Masson, R. Krishnadas, U. Volpe

    Research output: Contribution to JournalArticleAcademicpeer-review

    178 Downloads (Pure)

    Abstract

    Background: Little is known about the factors influencing treatment choice in psychosis, the majority of this work being conducted with specialists (consultant) in psychiatry. We sought to examine trainees' choices of treatment for psychosis if they had to prescribe it for themselves, their patients, and factors influencing decision-making.Methods: Cross-sectional, semi-structured questionnaire-based study.Results: Of the 726 respondents (response rate = 66%), the majority chose second-generation antipsychotics (SGAs) if they had to prescribe it for themselves (n = 530, 93%) or for their patients (n = 546, 94%). The main factor influencing choice was perceived efficacy, 84.8% (n = 475) of trainees stating this was the most important factor for the patient, and 77.8% (n = 404) stating this was the most important factor for their own treatment. Trainees with knowledge of trials questioning use of SGAs (CATIE, CUtLASS, TEOSS) were more likely to choose second-generation antipsychotics than those without knowledge of these trials (χ
    Original languageEnglish
    Article number27
    Pages (from-to)27
    JournalBMC Psychiatry
    Volume12
    DOIs
    Publication statusPublished - 2012

    Fingerprint

    Dive into the research topics of 'Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?'. Together they form a unique fingerprint.

    Cite this